Shikhar Mehrotra to ADP-ribosyl Cyclase 1
This is a "connection" page, showing publications Shikhar Mehrotra has written about ADP-ribosyl Cyclase 1.
Connection Strength
1.427
-
CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
Score: 0.668
-
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
Score: 0.583
-
CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020 07 17; 9(7).
Score: 0.176